News & Trends - MedTech & Diagnostics
Health insurers holding $1.8 billion excess funds from deferred claims
MedTech News: The Australian Private Hospitals Association (APHA) has welcomed the move by private health insurer HBF to repay members fees after accruing excess funds due to COVID-19 and is urging the big players to do the same.
Australian Private Hospitals Association (APHA) CEO Michael Roff said HBF’s move was ‘the right thing to do’, but noted it was restricted to the Western Australian-based insurer.
“This is exactly what health insurers should be doing – in fact we called for this very thing last week. The latest Australian Prudential Regulation Authority (APRA) data report showed there was $1.8 billion sitting in insurers’ bank accounts as deferred claims liability, if those funds are not used to address the backlog of elective surgery, then they should be returned to members.
“HBF is in a position to return $40 million to policyholders, imagine what the large insurers are holding back? For example, Medibank reported last week that they are holding $310 million in deferred claims,” he said.
On a national level, activity in private hospitals was down 6.9% in 2020 compared to 2019.
“This is not as bad as anticipated when elective surgery restrictions were first imposed, so it is likely all health funds are holding an excess of deferred claims liabilities.
“The latest data shows that in the six months to December 2020, private hospital activity bounced back to more normal levels, so there is no reason why all health funds can’t declare how much they will return to members.”
Mr Roff said it was pleasing to see at least one health insurer honouring its promise to members and he looks forward to hearing similar announcements from the big health insurance organisations.
“Australians have been hit hard by the pandemic and many will be facing a cut to JobKeeper at the end of this month. If private health insurers are holding on to money that could help those people out, they should do the right thing and follow HBF’s great example,” he said.
News & Trends - Pharmaceuticals
Lilly and Boehringer attract local trials to tackle obesity and its cardiovascular risks
Obesity remains a pressing public health issue, serving as a key driver of numerous complications, including atherosclerotic cardiovascular disease (ASCVD) […]
MoreNews & Trends - MedTech & Diagnostics
‘We need relief now; we can’t wait for another talkfest,’ asserts CEO of Day Hospitals Australia
The private healthcare sector is grappling with escalating tensions between private hospitals and health insurers, with no resolution in sight. […]
MoreNews & Trends - Pharmaceuticals
BeiGene’s BTK inhibitor delivers promising long-term results in newly released data
Bruton tyrosine kinase (BTK) inhibitors have improved treatment outcomes for patients with chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma […]
MoreCommunication
Mastering the art of saying ‘No’ to protect your career and well-being: Psychologist
As the year draws to a close, professionals and leaders alike are faced with increasing pressure to meet deadlines, complete […]
More